Opicapone as an adjunct to levodopa in patients with Parkinson's disease and end-of-dose motor fluctuations: a randomised, double-blind, controlled trial-Reference-Cited by-同舟云学术

Opicapone as an adjunct to levodopa in patients with Parkinson's disease and end-of-dose motor fluctuations: a randomised, double-blind, controlled trial

Published:2016-02 Issue:2 Volume:15 Page:154-165
ISSN:1474-4422
Container-title:The Lancet Neurology
language:en
Short-container-title:The Lancet Neurology

Author:

Ferreira Joaquim J,Lees Andrew,Rocha José-Francisco,Poewe Werner,Rascol Olivier,Soares-da-Silva Patrício

Publisher

Elsevier BV

Subject

Neurology (clinical)

Reference32 articles.

1. The Movement Disorder Society evidence-based medicine review update: treatments for the motor symptoms of Parkinson's disease;Fox;Mov Disord,2011

2. Summary of the recommendations of the EFNS/MDS-ES review on therapeutic management of Parkinson's disease;Ferreira;Eur J Neurol,2013

3. Clinical spectrum of levodopa-induced complications;Aquino;Mov Disord,2015

4. Impact of the motor complications of Parkinson's disease on the quality of life;Chapuis;Mov Disord,2005

5. Treatments for Parkinson disease—past achievements and current clinical needs;Poewe;Neurology,2009

Cited by 225 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cost-effectiveness Analysis of COMT-inhibitors as Adjuvant Treatments to Levodopa in Patients with Advanced Parkinson's Disease;Clinical Therapeutics;2024-09

2. Pharmacotherapy of motor symptoms in early and mid-stage Parkinson’s disease: guideline “Parkinson’s disease” of the German Society of Neurology;Journal of Neurology;2024-08-29

3. Opicapone for the treatment of early wearing-off in levodopa-treated Parkinson’s disease: pooled analysis of patient level data from two randomized open-label studies;Journal of Neurology;2024-08-21

4. Disease Stage and Motor Fluctuation Duration Predict Drug Tolerability: A Real-Life, Prospective Italian Multicenter Study on the Use of Opicapone in Parkinson’s Disease;Drugs - Real World Outcomes;2024-07-02

5. A Recyclable Luminescent MOF Sensor for On‐Site Detection of Insecticide Dinotefuran and Anti‐Parkinson's Drug Entacapone in Various Environmental and Biological Specimens;Chemistry – An Asian Journal;2024-06-26